BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25596108)

  • 1. Gastrointestinal dose-histogram effects in the context of dose-volume-constrained prostate radiation therapy: analysis of data from the RADAR prostate radiation therapy trial.
    Ebert MA; Foo K; Haworth A; Gulliford SL; Kennedy A; Joseph DJ; Denham JW
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):595-603. PubMed ID: 25596108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.
    Peeters ST; Lebesque JV; Heemsbergen WD; van Putten WL; Slot A; Dielwart MF; Koper PC
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1151-61. PubMed ID: 16414208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial.
    Yeoh EE; Fraser RJ; McGowan RE; Botten RJ; Di Matteo AC; Roos DE; Penniment MG; Borg MF
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):943-55. PubMed ID: 12605972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of radiation-induced gastrointestinal morbidity: A prospective, longitudinal study following radiotherapy for carcinoma of the prostate.
    Yeoh EK; Krol R; Dhillon VS; Botten R; Di Matteo A; Butters J; Brock AR; Esterman A; Salisbury C; Fenech M
    Acta Oncol; 2016 May; 55(5):604-10. PubMed ID: 27046049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?
    Kupelian PA; Reddy CA; Carlson TP; Willoughby TR
    Cancer J; 2002; 8(1):62-6. PubMed ID: 11895204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.
    Jackson A; Skwarchuk MW; Zelefsky MJ; Cowen DM; Venkatraman ES; Levegrun S; Burman CM; Kutcher GJ; Fuks Z; Liebel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):685-98. PubMed ID: 11172950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients.
    Schaake W; van der Schaaf A; van Dijk LV; Bongaerts AH; van den Bergh AC; Langendijk JA
    Radiother Oncol; 2016 Jun; 119(3):381-7. PubMed ID: 27157889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial.
    Yahya N; Ebert MA; Bulsara M; Haworth A; Kearvell R; Foo K; Kennedy A; Richardson S; Krawiec M; Joseph DJ; Denham JW
    Radiat Oncol; 2014 Dec; 9():282. PubMed ID: 25498565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications.
    Moulton CR; House MJ; Lye V; Tang CI; Krawiec M; Joseph DJ; Denham JW; Ebert MA
    Radiat Oncol; 2016 Oct; 11(1):144. PubMed ID: 27799048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
    Fiorino C; Fellin G; Rancati T; Vavassori V; Bianchi C; Borca VC; Girelli G; Mapelli M; Menegotti L; Nava S; Valdagni R
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1130-7. PubMed ID: 17881142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer.
    Koper PC; Heemsbergen WD; Hoogeman MS; Jansen PP; Hart GA; Wijnmaalen AJ; van Os M; Boersma LJ; Lebesque JV; Levendag P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1072-82. PubMed ID: 15001247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397.
    Gulliford SL; Foo K; Morgan RC; Aird EG; Bidmead AM; Critchley H; Evans PM; Gianolini S; Mayles WP; Moore AR; Sánchez-Nieto B; Partridge M; Sydes MR; Webb S; Dearnaley DP
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):747-54. PubMed ID: 19540054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
    Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial.
    Nguyen PL; Chen RC; Hoffman KE; Trofimov A; Efstathiou JA; Coen JJ; Shipley WU; Zietman AL; Talcott JA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1081-5. PubMed ID: 20207497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy.
    Fokdal L; Honoré H; Høyer M; von der Maase H
    Radiother Oncol; 2005 Feb; 74(2):203-10. PubMed ID: 15734208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response.
    Skwarchuk MW; Jackson A; Zelefsky MJ; Venkatraman ES; Cowen DM; Levegrün S; Burman CM; Fuks Z; Leibel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):103-13. PubMed ID: 10758311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional data analysis in NTCP modeling: a new method to explore the radiation dose-volume effects.
    Benadjaoud MA; Blanchard P; Schwartz B; Champoudry J; Bouaita R; Lefkopoulos D; Deutsch E; Diallo I; Cardot H; de Vathaire F
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):654-63. PubMed ID: 25304951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial.
    Brand DH; Brüningk SC; Wilkins A; Fernandez K; Naismith O; Gao A; Syndikus I; Dearnaley DP; Tree AC; van As N; Hall E; Gulliford S;
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):596-608. PubMed ID: 33412260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.
    Boersma LJ; van den Brink M; Bruce AM; Shouman T; Gras L; te Velde A; Lebesque JV
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):83-92. PubMed ID: 9588921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.